Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nicola Macarone Palmieri"'
Autor:
Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni
Publikováno v:
Italian Journal of Medicine, Vol 14, Iss 2 (2020)
Evaluation of clinical-laboratory-therapeutic management and related clinical outcomes (thrombotic-hemorrhagic complications) of patients undergoing treatment with direct oral anticoagulants (DOACs) during major bleeding. This is a two-year observati
Externí odkaz:
https://doaj.org/article/5c57e548205b4682b76c0f6b9cd52dd2
Autor:
Lucio Brugioni, Sara Mascia, Nicola Macarone Palmieri, Serena Scarabottini, Chiara Catena, Anna Maria Ferrari, Francesca Mori, Elisa Romagnoli
Publikováno v:
Italian Journal of Medicine, Vol 14, Iss 2 (2020)
Evaluation of clinical-laboratory-therapeutic management and related clinical outcomes (thrombotic-hemorrhagic complications) of patients undergoing treatment with direct oral anticoagulants (DOACs) during major bleeding. This is a two-year observati
Autor:
Roberta Lupoli, Anna Russolillo, Matteo Nicola Dario Di Minno, Nicola Macarone Palmieri, Agostino Buonauro, Giovanni Di Minno
Publikováno v:
Thrombosis Research. 129:341-344
In 2004 an editorial article on the so-called "aspirin resistance" and diabetic angiopathy as related to platelet turnover was published by one of us. An update of this issue is now presented. The evidence of an incomplete inhibition of platelet func
Autor:
Anna Maria Cerbone, Nicola Macarone Palmieri, Antonella Tufano, Fiorella Alfinito, Ernesto Cimino
Publikováno v:
Internal and Emergency Medicine. 4:75-77
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem cell disorder characterized by intravascular hemolytic anemia that results from the clonal expansion of hematopoietic stem cells harboring somatic mutations in an X-linked gene, termed P
Autor:
Daniela Coppola, Ciro De Simone, Francesco Lanza, Nicola Macarone Palmieri, Carlo Ruosi, Giovanni Di Minno, Antonio Coppola, Aldo Amoriello
Over the past 10 years recombinant activated factor VIIa (rFVIIa) has been successfully used for treatment and prophylaxis of bleeding in patients with platelet defects, including thrombocytopenia and congenital and acquired platelet function abnorma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5ac876434443c77bb62be2fb217620
http://hdl.handle.net/11392/2420363
http://hdl.handle.net/11392/2420363